Private Wealth Management Group’s Structure Therapeutics GPCR Stock Holding History

Private Wealth Management Group’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-196	Closed	-$13.6K	–	1494
2025 Q4	$13.6K	Hold	196	–	–	﹤0.01%	423
2025 Q3	$5.49K	Hold	196	–	–	﹤0.01%	760
2025 Q2	$4.07K	Hold	196	–	–	﹤0.01%	839
2025 Q1	$3.39K	Buy	+196	New	+$4.8K	﹤0.01%	873

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Private Wealth Management Group's GPCR Position: Q1 2026 in Review

Private Wealth Management Group sold out of Structure Therapeutics (GPCR) in Q1 2026, closing a stake of 196 shares — an estimated $13.6K sold.

Private Wealth Management Group first reported a position in GPCR in Q1 2025 and held it in 4 quarters. The position peaked at $13.6K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

Private Wealth Management Group reported no remaining Structure Therapeutics position as of Q1 2026 after selling out during the quarter.
Private Wealth Management Group sold 196 Structure Therapeutics shares in Q1 2026, an estimated $13.6K.
Private Wealth Management Group first reported a position in Structure Therapeutics in Q1 2025 and held it in 4 quarters.
Private Wealth Management Group's Structure Therapeutics position peaked at $13.6K in Q4 2025.
196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.